Terms: = Lung cancer AND HLF, Q16534, 3131, ENSG00000108924
64 results:
1. Intracellularly delivered human lactoferrin functions as an activator of Na
Kurimoto D; Hue Anh TD; Kasama R; Sato A
Biochem Biophys Res Commun; 2024 Feb; 695():149480. PubMed ID: 38215552
[TBL] [Abstract] [Full Text] [Related]
2. Second Primary lung cancer Among lung cancer Survivors Who Never Smoked.
Choi E; Su CC; Wu JT; Aredo JV; Neal JW; Leung AN; Backhus LM; Lui NS; Le Marchand L; Stram DO; Liang SY; Cheng I; Wakelee HA; Han SS
JAMA Netw Open; 2023 Nov; 6(11):e2343278. PubMed ID: 37966839
[TBL] [Abstract] [Full Text] [Related]
3. lung extracellular matrix modulates KRT5
Hewitt RJ; Puttur F; Gaboriau DCA; Fercoq F; Fresquet M; Traves WJ; Yates LL; Walker SA; Molyneaux PL; Kemp SV; Nicholson AG; Rice A; Roberts E; Lennon R; Carlin LM; Byrne AJ; Maher TM; Lloyd CM
Nat Commun; 2023 Sep; 14(1):6039. PubMed ID: 37758700
[TBL] [Abstract] [Full Text] [Related]
4. Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment.
Kurimoto D; Sato A
Eur J Pharm Sci; 2023 Dec; 191():106591. PubMed ID: 37742986
[TBL] [Abstract] [Full Text] [Related]
5. Construction of a genomic instability-derived predictive prognostic signature for non-small cell lung cancer patients.
Li W; Wu H; Xu J
Cancer Genet; 2023 Nov; 278-279():24-37. PubMed ID: 37579716
[TBL] [Abstract] [Full Text] [Related]
6. Efficient Endocytosis of the Human Lactoferrin N-Lobe Enhances Its Antiproliferative Activity against Human cancer Cells.
Nakamura M; Shiga A; Iimori A; Matsuzaki T
Biol Pharm Bull; 2023 Jul; 46(7):1004-1009. PubMed ID: 37088555
[TBL] [Abstract] [Full Text] [Related]
7. Exosomes derived from M1 macrophages inhibit the proliferation of the A549 and H1299 lung cancer cell lines via the miRNA-let-7b-5p-GNG5 axis.
Peng J; Li S; Li B; Hu W; Ding C
PeerJ; 2023; 11():e14608. PubMed ID: 36643646
[TBL] [Abstract] [Full Text] [Related]
8. Tumor-promoting roles of HMMR in lung adenocarcinoma.
Wang Q; Wu G; Fu L; Li Z; Wu Y; Zhu T; Yu G
Mutat Res; 2023; 826():111811. PubMed ID: 36603370
[TBL] [Abstract] [Full Text] [Related]
9. Albumin fusion with human lactoferrin shows enhanced inhibition of cancer cell migration.
Nopia H; Kurimoto D; Sato A
Biometals; 2023 Jun; 36(3):629-638. PubMed ID: 36167912
[TBL] [Abstract] [Full Text] [Related]
10. Hepatic leukemia factor-expressing paraxial mesoderm cells contribute to the developing brain vasculature.
Koui Y; Ideue T; Boylan M; Anderson MJ; Osato M; Suda T; Yokomizo T; Mukouyama YS
Biol Open; 2022 Sep; 11(9):. PubMed ID: 36017733
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptional regulation and small compound targeting of ACE2 in lung epithelial cells.
Liang LJ; Wang D; Yu H; Wang J; Zhang H; Sun BB; Yang FY; Wang Z; Xie DW; Feng RE; Xu KF; Wang GZ; Zhou GB
Acta Pharmacol Sin; 2022 Nov; 43(11):2895-2904. PubMed ID: 35468992
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations.
Chu YH; Barbee J; Yang SR; Chang JC; Liang P; Mullaney K; Chan R; Salazar P; Benayed R; Offin M; Drilon A; Ladanyi M; Nafa K; Arcila ME
J Mol Diagn; 2022 Jun; 24(6):642-654. PubMed ID: 35430374
[TBL] [Abstract] [Full Text] [Related]
13. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
[TBL] [Abstract] [Full Text] [Related]
14. Integrative Molecular Analyses of an Individual Transcription Factor-Based Genomic Model for lung cancer Prognosis.
Yao R; Zhou L; Guo Z; Zhang D; Zhang T
Dis Markers; 2021; 2021():5125643. PubMed ID: 34925645
[TBL] [Abstract] [Full Text] [Related]
15. A Novel Human Recombinant Lactoferrin Inhibits lung Adenocarcinoma Cell Growth and Migration with No Cytotoxic Effect on Normal Human Epithelial Cells.
Olszewska P; Pazdrak B; Kruzel ML
Arch Immunol Ther Exp (Warsz); 2021 Nov; 69(1):33. PubMed ID: 34748082
[TBL] [Abstract] [Full Text] [Related]
16. Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and
Guberina M; Darwiche K; Hautzel H; Pöttgen C; Guberina N; Gauler T; Ploenes T; Umutlu L; Theegarten D; Aigner C; Eberhardt WEE; Metzenmacher M; Wiesweg M; Karpf-Wissel R; Schuler M; Herrmann K; Stuschke M
Radiat Oncol; 2021 Sep; 16(1):176. PubMed ID: 34526050
[TBL] [Abstract] [Full Text] [Related]
17. Decreased hlf Expression Predicts Poor Survival in lung Adenocarcinoma.
Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
[TBL] [Abstract] [Full Text] [Related]
18. Fabrication of PNIPAm-based thermoresponsive hydrogel microwell arrays for tumor spheroid formation.
Dhamecha D; Le D; Chakravarty T; Perera K; Dutta A; Menon JU
Mater Sci Eng C Mater Biol Appl; 2021 Jun; 125():112100. PubMed ID: 33965110
[TBL] [Abstract] [Full Text] [Related]
19. Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma.
Huang J; Zhang Q; Shen J; Chen X; Ma S
Aging (Albany NY); 2021 Feb; 13(4):5946-5966. PubMed ID: 33612479
[TBL] [Abstract] [Full Text] [Related]
20. A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
Yang SR; Aypar U; Rosen EY; Mata DA; Benayed R; Mullaney K; Jayakumaran G; Zhang Y; Frosina D; Drilon A; Ladanyi M; Jungbluth AA; Rekhtman N; Hechtman JF
Clin Cancer Res; 2021 Mar; 27(5):1316-1328. PubMed ID: 33272981
[TBL] [Abstract] [Full Text] [Related]
[Next]
